These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26566803)

  • 21. Counting on natural products for drug design.
    Rodrigues T; Reker D; Schneider P; Schneider G
    Nat Chem; 2016 Jun; 8(6):531-41. PubMed ID: 27219696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of kaurane-type diterpenes from Parinari sprucei and their potential anticancer activity.
    Braca A; Armenise A; Morelli I; Mendez J; Mi Q; Chai HB; Swanson SM; Kinghorn AD; De Tommasi N
    Planta Med; 2004 Jun; 70(6):540-50. PubMed ID: 15229806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated Compounds from Natural Products with Potential Antidiabetic Activity - A Systematic Review.
    Munhoz ACM; Frode TS
    Curr Diabetes Rev; 2018; 14(1):36-106. PubMed ID: 28474555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
    Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
    Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioactive Peptide Natural Products as Lead Structures for Medicinal Use.
    Dang T; Süssmuth RD
    Acc Chem Res; 2017 Jul; 50(7):1566-1576. PubMed ID: 28650175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug development from natural products: exploiting synergistic effects.
    Ulrich-Merzenich G; Panek D; Zeitler H; Vetter H; Wagner H
    Indian J Exp Biol; 2010 Mar; 48(3):208-19. PubMed ID: 21046973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Exploring New Drug Targets through the Identification of Target Molecules of Bioactive Natural Products].
    Arai M
    Yakugaku Zasshi; 2016; 136(4):669-76. PubMed ID: 27040348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
    Li X; Wu Y; Wang Y; You Q; Zhang X
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
    [No Abstract]   [Full Text] [Related]  

  • 29. Midostaurin, a Natural Product-Derived Kinase Inhibitor Recently Approved for the Treatment of Hematological Malignancies
    Manley PW; Weisberg E; Sattler M; Griffin JD
    Biochemistry; 2018 Feb; 57(5):477-478. PubMed ID: 29188995
    [No Abstract]   [Full Text] [Related]  

  • 30. Syntheses of (-)-Tripterifordin and (-)-Neotripterifordin from Stevioside.
    Kobayashi S; Shibukawa K; Hamada Y; Kuruma T; Kawabata A; Masuyama A
    J Org Chem; 2018 Feb; 83(3):1606-1613. PubMed ID: 29328659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Array of Bioactive Compounds From Australian Eucalypts and Their Relevance in Pancreatic Cancer Therapeutics.
    Bhuyan DJ; Vuong QV; Chalmers AC; Bowyer MC; Scarlett CJ
    Pancreas; 2018 Jul; 47(6):690-707. PubMed ID: 29894418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trends in development of molecular targeted therapy for hematological neoplasms].
    Nagai T
    Rinsho Ketsueki; 2012 Oct; 53(10):1768-75. PubMed ID: 23037750
    [No Abstract]   [Full Text] [Related]  

  • 33. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
    Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
    Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.
    Camus V; Miloudi H; Taly A; Sola B; Jardin F
    J Hematol Oncol; 2017 Feb; 10(1):47. PubMed ID: 28196522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in translational pharmacological investigations in identifying and validating molecular targets of natural product anticancer agents.
    Yu J; Nag SA; Zhang R
    Curr Cancer Drug Targets; 2013 Jun; 13(5):596-609. PubMed ID: 23597194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment.
    Wu Q; Wong JPC; Kwok HF
    Cells; 2020 May; 9(5):. PubMed ID: 32414171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isolation and identification of two new diterpenoid from Rubus corchorifolius L. f].
    Zhang M; Cao Y; Du FL; Ou-Yang W; Yuan Y
    Yao Xue Xue Bao; 2007 Nov; 42(11):1155-8. PubMed ID: 18300471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation products of rubusoside under acidic conditions.
    Prakash I; Bunders C; Devkota KP; Charan RD; Hartz RM; Sears TL; Snyder TM; Ramirez C
    Nat Prod Commun; 2015 Apr; 10(4):559-62. PubMed ID: 25973475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to polycyclic 1,4-dioxygenated xanthones. Application to total synthesis of the aglycone of IB-00208.
    Yang J; Knueppel D; Cheng B; Mans D; Martin SF
    Org Lett; 2015 Jan; 17(1):114-7. PubMed ID: 25513888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.